Tracing the origins of relapse in acute myeloid leukaemia to stem cells
…, R Marke, JL McLeod, M Doedens, G Bader, V Voisin… - Nature, 2017 - nature.com
In acute myeloid leukaemia, long-term survival is poor as most patients relapse despite
achieving remission 1 . Historically, the failure of therapy has been thought to be due to …
achieving remission 1 . Historically, the failure of therapy has been thought to be due to …
Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap
Pathway enrichment analysis helps researchers gain mechanistic insight into gene lists
generated from genome-scale (omics) experiments. This method identifies biological pathways …
generated from genome-scale (omics) experiments. This method identifies biological pathways …
[HTML][HTML] Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21
A Hussain, V Voisin, S Poon, C Karamboulas… - Journal of Experimental …, 2020 - rupress.org
Recent studies indicate that cancer-associated fibroblasts (CAFs) are phenotypically and
functionally heterogeneous. However, little is known about CAF subtypes, the roles they play in …
functionally heterogeneous. However, little is known about CAF subtypes, the roles they play in …
[PDF][PDF] Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia
A Cole, Z Wang, E Coyaud, V Voisin, M Gronda… - Cancer cell, 2015 - cell.com
From an shRNA screen, we identified ClpP as a member of the mitochondrial proteome whose
knockdown reduced the viability of K562 leukemic cells. Expression of this mitochondrial …
knockdown reduced the viability of K562 leukemic cells. Expression of this mitochondrial …
[HTML][HTML] Quiescent Sox2+ cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma
…, R Head, S Morrissy, X Zhu, T Aviv, V Voisin… - Cancer cell, 2014 - cell.com
Functional heterogeneity within tumors presents a significant therapeutic challenge. Here
we show that quiescent, therapy-resistant Sox2 + cells propagate sonic hedgehog subgroup …
we show that quiescent, therapy-resistant Sox2 + cells propagate sonic hedgehog subgroup …
[PDF][PDF] miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells
…, KG Hermans, K Eppert, R Marke, R Isserlin, V Voisin… - Cancer cell, 2016 - cell.com
To investigate miRNA function in human acute myeloid leukemia (AML) stem cells (LSC),
we generated a prognostic LSC-associated miRNA signature derived from functionally …
we generated a prognostic LSC-associated miRNA signature derived from functionally …
A comparative transcriptomic analysis reveals conserved features of stem cell pluripotency in planarians and mammals
…, A Lin, SJ Zhu, DDR Brown, EJ Ross, V Voisin… - Stem …, 2012 - academic.oup.com
Many long‐lived species of animals require the function of adult stem cells throughout their
lives. However, the transcriptomes of stem cells in invertebrates and vertebrates have not …
lives. However, the transcriptomes of stem cells in invertebrates and vertebrates have not …
[PDF][PDF] Attenuation of miR-126 activity expands HSC in vivo without exhaustion
…, H Hiramatsu, U Restuccia, A Bachi, V Voisin… - Cell stem cell, 2012 - cell.com
Lifelong blood cell production is governed through the poorly understood integration of cell-intrinsic
and -extrinsic control of hematopoietic stem cell (HSC) quiescence and activation. …
and -extrinsic control of hematopoietic stem cell (HSC) quiescence and activation. …
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
…, WC Chen, HA Abbas, M Chan-Seng-Yue, V Voisin… - Nature medicine, 2022 - nature.com
The treatment landscape of acute myeloid leukemia (AML) is evolving, with promising
therapies entering clinical translation, yet patient responses remain heterogeneous, and …
therapies entering clinical translation, yet patient responses remain heterogeneous, and …
Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs
…, MN Edmonson, X Ma, Y Fan, V Voisin… - Cancer discovery, 2020 - AACR
Isolation and characterization of subclones from diagnosis samples of patients with B-ALL
who relapsed showed that relapse-fated subclones had increased drug tolerance and distinct …
who relapsed showed that relapse-fated subclones had increased drug tolerance and distinct …